According to the studies, mutations related to the expression of the msh6 gene are associated with a lower risk of cancer compared to the mutations of the mlh1 or msh2 genes, and those who carry mutations in the expression of the msh6 gene at an older age are also more likely to develop CRC. This evidence concerns the gene MSH2 and colorectal carcinoma.